Immunoprophylaxie RH chez les patientes RH1 partiel : intérêt d’un test de consommation in vitro
Aline Floch(Inserm), Agnès Mailloux(Sorbonne Université), France Pirenne(Inserm), Stéphanie Huguet‐Jacquot(Assistance Publique – Hôpitaux de Paris), A. Cortey(Sorbonne Université), Cécile Toly‐Ndour(Sorbonne Université), B. Carbonne(Princess Grace Hospital Centre)
Cited by 0
Related Papers
ABO blood group and COVID‐19: a review on behalf of the ISBT COVID‐19 Working Group
|Vox Sanguinis|2021|154
mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants
|Immunity|2021|143
Proteomic study of human umbilical vein endothelial cells in culture
|PROTEOMICS|2003|100
Anticancer drugs induce necrosis of human endothelial cells involving both oncosis and apoptosis
|European Journal of Cell Biology|2001|82